CTLA-4Ig: Uses and Future Directions

Publisher： Bentham Science Publishers

E-ISSN： 2212-2710|3|2|132-142

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.3, Iss.2, 2009-06, pp. : 132-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Omalizumab for Asthma: Indications, Off-Label Uses and Future Directions

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 4, Iss. 3, 2010-11 ,pp. : 183-192

Bentham Science Publishers

Access to resources Recommend Favorite

Bench to Bedside of CTLA-4: A Novel Immuno-Therapeutic Agent for Inflammatory Disorders

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 3, Iss. 2, 2009-06 ,pp. : 84-95

Bentham Science Publishers

Access to resources Recommend Favorite

Guest Editorial: Future Directions in NDE and Structural Health Monitoring

By Cruse Thomas A.  

Journal of Nondestructive Evaluation, Vol. 23, Iss. 3, 2004-09 ,pp. : 77-79

Springer Publishing Company

Access to resources Recommend Favorite

Liposheres as a Novel Carrier for Lipid Based Drug Delivery: Current and Future Directions

By  

Recent Patents on Drug Delivery & Formulation, Vol. 10, Iss. 1, 2016-04 ,pp. : 59-71

Bentham Science Publishers

Access to resources Recommend Favorite

Linagliptin and Newer DPP-4 Inhibitors: Newer Uses and Newer Indications

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, Iss. 3, 2011-09 ,pp. : 197-202

Bentham Science Publishers

Access to resources Recommend Favorite